Perfluorooctanoic acid (PFOA) affects distinct molecular signalling pathways in human primary hepatocytes

Toxicology. 2015 Jul 3:333:53-62. doi: 10.1016/j.tox.2015.04.004. Epub 2015 Apr 11.

Abstract

Perfluorooctanoic acid (PFOA) was shown to damage the liver of rodents and to impair embryonic development. At the molecular level, the hepatotoxic effects were attributed to the PFOA-mediated activation of peroxisome proliferator-activated receptor alpha (PPARα). In general, PPARα-dependent effects are less pronounced in humans than in rodents, and the hazard potential of PFOA for humans is controversially discussed. To analyse the effects of PFOA in human hepatocytes, a microarray analysis was conducted to screen for PFOA-mediated alterations in the transcriptome of human primary hepatocytes. A subsequent network analysis revealed that PFOA had an impact on several signalling pathways in addition to the well-known activation of PPARα. The microarray data confirmed earlier findings that PFOA: (i) affects the estrogen receptor ERα, (ii) activates the peroxisome proliferator-activated receptor gamma (PPARγ), and (iii) inhibits the function of the hepatocyte nuclear factor 4α (HNF4α) which is an essential factor for liver development and embryogenesis. Finally, as a novel finding, PFOA was shown to stimulate gene expression of the proto-oncogenes c-Jun and c-Fos. This was confirmed by using the HepG2 cell line as a model for human hepatocytes. PFOA stimulated cellular proliferation and the metabolic activity of the cells, and upregulated the expression of various cyclins which have a central function in the regulation of cell cycle control. Functional studies, however, indicated that PFOA had no impact on c-Jun and c-Fos phosphorylation and on AP-1-dependent gene transcription, thus demonstrating that PFOA-induced proliferation occurs largely independent of c-Jun and c-Fos.

Keywords: Cell cycle regulation; Hepatocyte; PFOA; Transcriptomics.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Caprylates / toxicity*
  • Cell Cycle / drug effects
  • Cell Proliferation / drug effects
  • Chemical and Drug Induced Liver Injury / etiology*
  • Chemical and Drug Induced Liver Injury / genetics
  • Chemical and Drug Induced Liver Injury / metabolism
  • Chemical and Drug Induced Liver Injury / pathology
  • Cyclins / genetics
  • Cyclins / metabolism
  • Dose-Response Relationship, Drug
  • Estrogen Receptor alpha / agonists
  • Estrogen Receptor alpha / genetics
  • Estrogen Receptor alpha / metabolism
  • Fluorocarbons / toxicity*
  • Gene Expression Profiling / methods
  • Gene Expression Regulation
  • Gene Regulatory Networks
  • Hep G2 Cells
  • Hepatocyte Nuclear Factor 4 / antagonists & inhibitors
  • Hepatocyte Nuclear Factor 4 / genetics
  • Hepatocyte Nuclear Factor 4 / metabolism
  • Hepatocytes / drug effects*
  • Hepatocytes / metabolism
  • Hepatocytes / pathology
  • Humans
  • Oligonucleotide Array Sequence Analysis
  • PPAR alpha / agonists
  • PPAR alpha / genetics
  • PPAR alpha / metabolism
  • PPAR gamma / agonists
  • PPAR gamma / genetics
  • PPAR gamma / metabolism
  • Primary Cell Culture
  • Proto-Oncogene Proteins c-fos / genetics
  • Proto-Oncogene Proteins c-fos / metabolism
  • Proto-Oncogene Proteins c-jun / genetics
  • Proto-Oncogene Proteins c-jun / metabolism
  • Signal Transduction / drug effects*
  • Time Factors
  • Transcription Factor AP-1 / genetics
  • Transcription Factor AP-1 / metabolism
  • Transcriptome

Substances

  • Caprylates
  • Cyclins
  • ESR1 protein, human
  • Estrogen Receptor alpha
  • Fluorocarbons
  • HNF4A protein, human
  • Hepatocyte Nuclear Factor 4
  • PPAR alpha
  • PPAR gamma
  • Proto-Oncogene Proteins c-fos
  • Proto-Oncogene Proteins c-jun
  • Transcription Factor AP-1
  • perfluorooctanoic acid